ClinicalTrials.gg
Not yet recruitingNCT07834892Updated Sep 22, 2026

Does Adding a Fascial Layer to the Cartilage in Tympanoplasty for Large Tympanic Membrane Perforation Affect the Overall Results?

An interventional study of Conchal Cartilage and Perichondrium Tympanoplasty and Conchal Cartilage, Perichondrium, and Temporalis Fascia Tympanoplasty in Tympanic Membrane Perforation, Otitis Media and Suppurative Otitis Media, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-22.

Sponsored by Assiut University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Large tympanic membrane (eardrum) perforations present a surgical challenge and are historically associated with lower graft take rates compared to smaller perforations. While autologous cartilage provides durable structural support and resistance to retraction, surgeons differ on whether placing an additional layer of temporalis fascia over the cartilage graft improves anatomical closure and functional hearing.

The primary purpose of this study is to determine whether adding a temporalis fascia layer to a conchal cartilage and perichondrium graft improves graft healing rates and audiological outcomes in patients undergoing tympanoplasty for large or subtotal perforations.

Adult participants with safe chronic suppurative otitis media and large or subtotal tympanic membrane perforations are randomly assigned in a 1:1 ratio to one of two surgical arms:

  • Group A:Tympanoplasty using an autologous conchal cartilage graft with attached perichondrium alone.
  • Group B: Tympanoplasty using an autologous conchal cartilage and perichondrium graft reinforced with an additional outer layer of temporalis fascia placed between the cartilage and the tympanic membrane remnant.

All participants undergo clinical otomicroscopy/otoendoscopy to assess graft take, healing, and complications, alongside pure-tone audiometry (evaluating air-bone gap and hearing thresholds) preoperatively and at 6 months postoperatively.

02

Conditions studied

  • Tympanic Membrane Perforation
  • Otitis Media
  • Suppurative Otitis Media
  • Chronic Suppurative Otitis Media

Keywords

  • Tympanoplasty
  • Cartilage Tympanoplasty
  • Temporalis Fascia
  • Conchal Cartilage
  • Myringoplasty
  • Air-Bone Gap
  • Graft Take
03

In context

Tympanic Membrane Perforation

53 studies on the registry are indexed under Tympanic Membrane Perforation; 14 are open to participants now.

This study's planned enrollment of 50 is below the median of 57 across 39 interventional studies indexed under Tympanic Membrane Perforation.

Browse Tympanic Membrane Perforation studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years and older
  • Presence of a large or subtotal tympanic membrane perforation
  • Safe chronic suppurative otitis media (CSOM)
  • Undergoing primary or revision tympanoplasty

Exclusion criteria

Exclusion Criteria:

  • Unsafe ear (e.g., presence of cholesteatoma, marginal perforation, or attic pathology)
  • Small or medium-sized tympanic membrane perforations
  • Age younger than 18 years
  • Patients unwilling or unable to attend scheduled postoperative follow-up visits through 6 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    Group A: Cartilage and Perichondrium

    Participants undergoing tympanoplasty for large or subtotal tympanic membrane perforations using conchal cartilage with perichondrium graft alone.

    Procedure: Conchal Cartilage and Perichondrium Tympanoplasty

  • Experimental
    Group B: Cartilage, Perichondrium, and Temporalis Fascia

    Participants undergoing tympanoplasty for large or subtotal tympanic membrane perforations using conchal cartilage with perichondrium combined with an additional temporalis fascia layer placed outside the cartilage graft between the cartilage and the tympanic membrane remnant.

    Procedure: Conchal Cartilage, Perichondrium, and Temporalis Fascia Tympanoplasty

Interventions

  • ProcedureConchal Cartilage and Perichondrium Tympanoplasty

    Surgical reconstruction of large or subtotal tympanic membrane perforations using an autologous conchal cartilage graft with attached perichondrium alone.

  • ProcedureConchal Cartilage, Perichondrium, and Temporalis Fascia Tympanoplasty

    Surgical reconstruction of large or subtotal tympanic membrane perforations using an autologous conchal cartilage and perichondrium graft combined with an additional layer of temporalis fascia positioned outside the cartilage graft between the cartilage and the tympanic membrane remnant.

06

What researchers measure

Primary outcomes

  1. Rate of Complete Tympanic Membrane Closure

    Evaluated by otomicroscopic or otoendoscopic examination. Complete closure is defined as an intact graft with total epithelialization and closure of the tympanic membrane perforation, with no residual or recurrent perforation.

    Time frame: 6 months postoperatively

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07834892
Lead sponsor
Assiut University
Responsible party
Enas Saad Khalil (Resident, Assiut University) — Principal investigator
First posted
Sep 22, 2026
Start date
Oct 2026 (estimated)
Primary completion
Oct 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Sep 22, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion